Establishment and practice of pharmaceutical service pathway in Parkinson's disease combined medical clinic
Objective To establish pharmaceutical service pathway in combined medical clinic for Parkinson's disease patients and ensure the normalization of pharmaceutical services.Methods Based on the current investigation results,the working mode of pharmaceutical services for Parkinson's disease patients was established,including medication plan evaluation,medication consultation,and personalized education.And 50 PD patients who visited our combined medical clinic from July to December 2022 were carried out according to the pharmaceutical service pathway,and the effectiveness was evaluated.Results After 6 months of service using this pathway,the UPDRS comprehensive scores of 50 PD patients in parts Ⅲ and Ⅳ were lower than those before service,and the difference was statistically significant(P<0.05).The Morisky score of 0(good compliance)increased from 7 to 25 people before and after service,and the score of 3～4(poor compliance)decreased from 13 to 2 people.In addition,no serious adverse reactions were observed during the follow-up period.Conclusion Establishing pharmaceutical service pathway in combined medical clinic for Parkinson's disease patients can increase medication compliance,improve clinical efficacy,reduce adverse reactions,and promote standardization of pharmaceutical outpatient service work.
Parkinson's diseaseCombined medical clinicPharmaceutical service
NETL
NSTL
万方数据
